Lineage vs Public Storage
LINE and PSA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LINE and PSA compare
Public Storage is the larger company, worth 7.0 times as much as Lineage ($57.0B against $8.2B).
Public Storage grew revenue faster over the last twelve months (3.0% versus 1.0% for Lineage).
Public Storage keeps more of each dollar of sales as profit, with a net margin of 41.8% compared with −3.1% at Lineage.
Both pay dividends: Lineage yields 5.9% and Public Storage 3.7%.
Public Storage scores higher on the StockData Score (12 against 8 for Lineage), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LINE | PSA |
|---|---|---|
| Size and price | ||
| Market cap | $8.2B | $57.0B |
| Share price | $36.00 | $324.77 |
| Change, 1 year | −5.9% | 12.3% |
| Change, 5 years | – | 0.59% |
| Beta (5Y) | 0.56 | 0.74 |
| Employees | 24K | 5,770 |
| StockData Score | ||
| Total score | 8 | 12 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 0 | 5 (better) |
| Dividend score | 3 (better) | 1 |
| Valuation | ||
| P/E | – | 31.0× |
| P/S | 1.5× (better) | 11.7× |
| P/B | 1.0× (better) | 6.2× |
| EV/EBITDA | 13.7× (better) | 16.1× |
| P/FCF | 33.6× | – |
| FCF yield | 3.0% | – |
| Fair value | $39.23 | $252.73 |
| Margin of safety | 8.2% (better) | −28.5% |
| Growth | ||
| Revenue growth (TTM) | 1.0% | 3.0% (better) |
| Revenue growth, 5Y average | – | 10.6% |
| Net income growth (TTM) | – | 12.9% |
| EPS growth (TTM) | – | 14.3% |
| EPS growth, 5Y average | – | 7.5% |
| Profitability | ||
| Gross margin | 32.0% | – |
| Operating margin | 3.6% | – |
| Net margin | −3.1% | 41.8% (better) |
| FCF margin | 4.5% | – |
| Return on equity | −2.0% | 22.0% (better) |
| Return on invested capital | 1.1% | – |
| Financial health | ||
| Debt / equity | 0.79 (better) | 0.00 |
| Net debt / EBITDA | 5.50 (better) | −0.07 |
| Interest coverage | 0.7× | – |
| Current ratio | 0.78 | – |
| Altman Z-score | 0.58 | 3.31 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 5.9% (better) | 3.7% |
| Years of dividend growth | 2 (better) | 0 |
| Dividend growth, 5Y average | – | 8.4% |
| Shareholder yield | 5.9% (better) | 3.7% |
| Ownership | ||
| Held by institutions | 33.7% | 87.1% |
| Held by insiders | – | 10.0% |
| Insider net buying, 12 months | $7.1M (better) | −$772K |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | – | 4.2% |
Go deeper
- LINE stock overview
- LINE income statement
- LINE valuation and score
- PSA stock overview
- PSA income statement
- PSA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.